Sign up to save your podcasts
Or
Share Solange Peters, MD, PhD - Harnessing Frontline Dual Immunotherapy and Chemotherapy Combination Regimens for Advanced NSCLC: Strategies to Enhance Individualized Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Solange Peters, MD, PhD - Harnessing Frontline Dual Immunotherapy and Chemotherapy Combination Regimens for Advanced NSCLC: Strategies to Enhance Individualized Care
Please visit answersincme.com/BTD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses available and emerging frontline dual immunotherapy plus chemotherapy combination regimens for the treatment of patients with advanced non–small-cell lung cancer (NSCLC). Upon completion of this activity, participants should be able to: Review the role of PD-L1 expression in the selection of frontline immunotherapeutic regimens for patients with advanced NSCLC, with a focus on available and emerging frontline dual immunotherapy and chemotherapy combination regimens; Describe the clinical profiles of available and emerging frontline dual immunotherapy plus chemotherapy combination regimens for the treatment of patients with advanced NSCLC; and Outline strategies to integrate available and emerging dual immunotherapy and chemotherapy combination regimens into frontline settings through optimal patient selection and management.
View all episodes
By Answers in CME
5
66 ratings
Please visit answersincme.com/BTD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses available and emerging frontline dual immunotherapy plus chemotherapy combination regimens for the treatment of patients with advanced non–small-cell lung cancer (NSCLC). Upon completion of this activity, participants should be able to: Review the role of PD-L1 expression in the selection of frontline immunotherapeutic regimens for patients with advanced NSCLC, with a focus on available and emerging frontline dual immunotherapy and chemotherapy combination regimens; Describe the clinical profiles of available and emerging frontline dual immunotherapy plus chemotherapy combination regimens for the treatment of patients with advanced NSCLC; and Outline strategies to integrate available and emerging dual immunotherapy and chemotherapy combination regimens into frontline settings through optimal patient selection and management.
More shows like CME in Minutes: Education in Oncology & Hematology
View all
Planet Money
30,670 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
12 Listeners
This Week in Cardiology
881 Listeners
Oncology Today with Dr Neil Love
57 Listeners
CCO Oncology Podcast
9 Listeners
CME in Minutes: Education in Dermatology
3 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners
CME in Minutes: Education in Ophthalmology
0 Listeners
CME in Minutes: Education in Cardiology & Pulmonology
3 Listeners
CME in Minutes: Education in Primary Care
6 Listeners
CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
5 Listeners